8-K: Lifeway Foods Rejects Danone's Acquisition Offers, Cites Undervaluation and Strategic Growth Potential

Lifeway Foods has rejected acquisition offers from Danone, asserting that the offers substantially undervalue the company and its future growth prospects.

Summary

• Lifeway Foods has responded to Danone's acquisition offers, stating that the offers of $25 and $27 per share significantly undervalue the company.
• The company projects net sales for the three months ending December 31, 2024, to be between $45.1 million and $46.6 million, up from $42.1 million in the same period of 2023.
• Full-year 2024 net sales are projected to be between $185.0 million and $186.5 million, an increase from $160.1 million in 2023.
• Lifeway forecasts annual Adjusted EBITDA to grow from $22 million in 2023 to between $45 million and $50 million in 2027.
• The company believes its standalone plan has the potential to provide superior value to shareholders compared to Danone's offer.
• Lifeway disputes Danone's claims regarding the validity of a 1999 Shareholder Agreement, asserting it is not valid under Illinois law.
• The company defends its CEO's updated employment agreement, stating it does not increase compensation from 2023 levels and includes non-compete and non-solicitation provisions.

Sentiment

Score: 7

Explanation: The document conveys a positive outlook for Lifeway's financial performance and strategic direction, but there are also some negative aspects related to the dispute with Danone and the validity of the Shareholder Agreement. The overall sentiment is positive but with some caution.

Positives

• Lifeway is experiencing strong revenue growth, with both quarterly and full-year sales projected to increase significantly.
• The company anticipates substantial growth in Adjusted EBITDA over the next few years.
• Lifeway's CEO has a strong track record of growth and shareholder value creation.
• The company's board believes its standalone plan offers better value to shareholders than Danone's acquisition offer.
• The CEO's new employment agreement includes non-compete and non-solicitation clauses, which benefit the company.

Negatives

• Danone's acquisition offers were deemed inadequate by Lifeway's board, indicating a potential conflict in valuation.
• There is a dispute over the validity of a 1999 Shareholder Agreement, which could lead to legal challenges.
• The company has not completed its fourth quarter and full year 2024 closing and review process, and the final results may differ from the preliminary estimates.
• The company's projections are based on preliminary and unaudited data, which may be subject to change.

Risks

• The company's financial projections are subject to risks and uncertainties, including price competition, customer decisions, and changes in commodity prices.
• There is a risk that the company's actual fourth quarter and full year 2024 net sales may differ from the preliminary expectations.
• The ongoing dispute with Danone could lead to further legal and financial challenges.
• The company's ability to achieve its projected EBITDA growth is not guaranteed and depends on various factors.

Future Outlook

Lifeway expects continued growth in net sales and Adjusted EBITDA, with a focus on executing its standalone business plan. The company anticipates significant growth in Adjusted EBITDA by 2027.

Management Comments

• The Board takes its fiduciary duties seriously and strongly disputes the assertion of Danone North America PBC that the Board's carefully considered decision to reject Danone's inadequate offer, or that its decision to issue shares earned by the Company's CEO since 2021 in line with market compensation practices, is in breach of those duties.
• The Board determined that Danone's $27.00 per share proposal substantially undervalues the Company.
• The Board believes that the Company's standalone plan has the potential to provide value to all shareholders superior to Danone's offer.
• The Board stands fully behind its decisions regarding Ms. Smolyansky's December 23, 2024 Amended and Restated Employment Agreement and Retention Bonus Agreement.
• The Board believes that her continued stewardship is critical to ensuring the success of the Company's standalone business plan.

Industry Context

The rejection of Danone's offer highlights the ongoing consolidation and acquisition activity in the food and beverage industry. Lifeway's focus on its standalone plan suggests confidence in its ability to compete and grow independently.

Comparison to Industry Standards

• Lifeway's projected EBITDA growth to $45-50 million by 2027 is significant, especially when compared to the implied 7.5x-8.5x EBITDA multiple of Danone's offer. This suggests that the company believes it is undervalued compared to industry peers.
• The document does not provide specific comparable companies, but the reference to 'high growth food and beverage peers' suggests that Lifeway is benchmarking itself against companies with similar growth trajectories.
• The 788% and 270% shareholder returns over the past five and three years respectively, as measured through September 23, 2024, indicate strong performance compared to the S&P 500 and other high-growth peers.

Legal Proceedings

• There is an ongoing dispute with Danone regarding the validity of the 1999 Shareholder Agreement.

Stakeholder Impact

• Shareholders are expected to benefit from the company's continued growth and the potential for higher valuation.
• Employees are likely to be impacted by the company's strategic decisions and the ongoing dispute with Danone.
• Customers and suppliers may be indirectly affected by the company's performance and strategic direction.

Next Steps

• Lifeway will continue to execute its standalone business plan.
• The company will continue to engage with Danone's counsel regarding the acquisition offer and the Shareholder Agreement.
• Lifeway will complete its fourth quarter and full year 2024 closing and review process.

Key Dates

Keywords

Lifeway Foods, Danone, Acquisition, Net Sales, Adjusted EBITDA, Shareholder Agreement, Valuation, Growth, Offer, Rejection